Abbott | ABT - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 10.46B 1.15B 2026-06
Agilent USD 1.44B 9M 2026-03
AtriCure USD 140.72M 2.71M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Bio-Rad Laboratories USD 6.85B 6.21B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
Cooper Companies USD 1.11B 301.2M 2026-03
Danaher USD 52.95B 47.61B 2026-03
Dexcom USD 936.6M 0 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 595.85M 49.26M 2026-03
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
Intuitive Surgical USD 1.91B 3.6M 2026-06
J&J USD 17.83B 388M 2026-06
Medtronic USD 7.72B 436M 2026-03
Merit Medical Systems USD 337.72M 2.02M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Smith & Nephew USD 2.52B 84M 2025-12
Solventum Corp USD 4.97B 3.08B 2026-03
Stryker USD 4.92B 284M 2026-03
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 3.08B 2.55B 2026-03
Terumo JPY 268.87B 16.12B 2026-03
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03